What are the Treatment Options for Ankylosing Spondylitis?
Because symptoms of AS can range from mild to severe, some people can manage their symptoms with nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen diclofenac, and naproxen sodium.
If your symptoms don’t respond to those drugs, prescription medications are the next line of defense which are biologics.
What are biologics for Ankylosing spondylitis?
Biologics are genetically engineered proteins created from living organisms that mimic normal biological functions. They’re targeted therapies aimed at specific proteins in the immune system that produce inflammation, namely:
tumor necrosis factor (TNF)
interleukin 17 (IL-17)
They were first approved in 1988 to treat rheumatoid arthritis. Since then, several other biologics have been developed. Currently, seven types of biologics are approved for the treatment of Ankylosing spondylitis. Some of drugs available in Kenya include etanercept (Enbrel), golimumab (Simponi,) and infliximab (Remicade)
Physiotherapy and stretching exercises also play an important role in reducing the stiffness from the disease